Related references
Note: Only part of the references are listed.566 Infliximab Concentration and Clinical Outcome in Patients With Ulcerative Colitis
Walter Reinisch et al.
GASTROENTEROLOGY (2015)
Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2014)
Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2014)
Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients
K. J. Schmidt et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE
R. Panaccione et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelines
J. D. Feuerstein et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease
Shomron Ben-Horin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Adalimumab in active ulcerative colitis: A real-life observational study
Alessandro Armuzzi et al.
DIGESTIVE AND LIVER DISEASE (2013)
Topical Tacrolimus Therapy for Antibiotic-Refractory Pouchitis
Motoi Uchino et al.
DISEASES OF THE COLON & RECTUM (2013)
Low allopurinol doses are sufficient to optimize azathioprine therapy in inflammatory bowel disease patients with inadequate thiopurine metabolite concentrations
Ivanka Curkovic et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Temporary adalimumab dose escalation is effective in Crohn's disease patients with secondary non-response
K. Sutharshan et al.
Journal of Crohns & Colitis (2013)
Immunosuppression-Related Lymphomas and Cancers in IBD: How Can They Be Prevented?
Laurent Beaugerie
DIGESTIVE DISEASES (2012)
Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
Paul Rutgeerts et al.
GASTROENTEROLOGY (2012)
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2012)
Adalimumab in steroid-dependent Crohn's disease patients: Prognostic factors for clinical benefit
Ambrogio Orlando et al.
INFLAMMATORY BOWEL DISEASES (2012)
Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: A retrospective observational study
Mats Sjoberg et al.
INFLAMMATORY BOWEL DISEASES (2012)
Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease
Casper Steenholdt et al.
INFLAMMATORY BOWEL DISEASES (2012)
Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis
Haruhiko Ogata et al.
INFLAMMATORY BOWEL DISEASES (2012)
Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy
Lennard P. L. Gilissen et al.
JOURNAL OF CROHNS & COLITIS (2012)
Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: Early and long-term data from a retrospective observational study
Filippo Mocciaro et al.
JOURNAL OF CROHNS & COLITIS (2012)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Axel Dignass et al.
JOURNAL OF CROHNS & COLITIS (2012)
Thalidomide Use and Outcomes in Pediatric Patients With Crohn Disease Refractory to Infliximab and Adalimumab
Lina M. Felipez et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2012)
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
David Laharie et al.
LANCET (2012)
Effectiveness of infliximab after adalimumab failure in Crohn's disease
Maria Chaparro et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab
C. Taxonera et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients
Y. Gonzalez-Lama et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Systematic review: the role of tacrolimus in the management of Crohn's disease
K. McSharry et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Efficacy of Immunosuppressive Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Khurram J. Khan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Alexander C. Ford et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease
Solmaz Ehteshami-Afshar et al.
ARCHIVES OF MEDICAL SCIENCE (2011)
The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease
Ambrogio Orlando et al.
DIGESTIVE AND LIVER DISEASE (2011)
Relapse Rate Following Azathioprine Withdrawal in Maintaining Remission for Crohn's Disease: A Meta-Analysis
Helen French et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Increased Risk of Nonmelanoma Skin Cancers Among Individuals With Inflammatory Bowel Disease
Harminder Singh et al.
GASTROENTEROLOGY (2011)
Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
Laurent Peyrin-Biroulet et al.
GASTROENTEROLOGY (2011)
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
Walter Reinisch et al.
GUT (2011)
Use of Thiopurine Testing in the Management of Inflammatory Bowel Diseases in Clinical Practice: A Worldwide Survey of Experts
Xavier Roblin et al.
INFLAMMATORY BOWEL DISEASES (2011)
Cyclosporine is Safe and Effective in Patients With Severe Ulcerative Colitis
Adam S. Cheifetz et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)
Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease
Casper Steenholdt et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Clinical trial: colectomy after rescue therapy in ulcerative colitis-3-year follow-up of the Swedish-Danish controlled infliximab study
A. Gustavsson et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease
Waqqas Afif et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
Millie D. Long et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Hepatosplenic T-Cell Lymphoma in a Young Man With Crohn's Disease: Case Report and Literature Review
Mark G. Ochenrider et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2010)
Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis
C. H. Seow et al.
GUT (2010)
Azathioprine Maintains Long-term Steroid-free Remission Through 3 Years in Patients with Steroid-dependent Ulcerative Colitis
Liliana Andrade Chebli et al.
INFLAMMATORY BOWEL DISEASES (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
A. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease
U. Hindorf et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine mercaptopurine
M. Wahed et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Risk of Lymphoma Associated With Combination Anti-Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis
Corey A. Siegel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease
Konstantinos Karmiris et al.
GASTROENTEROLOGY (2009)
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
H. Fidder et al.
GUT (2009)
Epstein-Barr Virus-associated Lymphoproliferation Awareness in Hemophagocytic Syndrome Complicating Thiopurine Treatment for Crohn's Disease
C. Serrate et al.
INFLAMMATORY BOWEL DISEASES (2009)
Mucosal Healing Predicts Long-term Outcome of Maintenance Therapy with Infliximab in Crohn's Disease
Fabian Schnitzler et al.
INFLAMMATORY BOWEL DISEASES (2009)
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Laurent Beaugerie et al.
LANCET (2009)
Rectal tacrolimus in the treatment of resistant ulcerative proctitis
I. C. Lawrance et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience
A. Oussalah et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis
S. Yamamoto et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: Meta-analysis of placebo-controlled trials
Laurent Peyrin-Biroulet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Hepatosplenic T cell lymphoma in inflammatory bowel disease
Matthew Shale et al.
GUT (2008)
The effect of tacrolimus (FK-506) on Japanese patients with refractory Crohn's disease
Hiroyuki Tamaki et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease:: an open randomised trial
Geert D'Haens et al.
LANCET (2008)
Share Paper
